{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:11:34Z","timestamp":1761844294361},"reference-count":44,"publisher":"Computers, Materials and Continua (Tech Science Press)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["oncol res"],"published-print":{"date-parts":[[2013,11,15]]},"abstract":"<jats:p>VSV-G-pseudotyped lentiviral vectors expressing p16<jats:sup>INK4a<\/jats:sup> or p14<jats:sup>ARF<\/jats:sup> were used to infect at high-efficiency Philadelphia chromosome (Ph)-positive leukemia cell lines lacking endogenous transcripts. Restoration of p16<jats:sup>INK4a<\/jats:sup> accumulated cells in the G<jats:sub>0<\/jats:sub>\/G<jats:sub>1<\/jats:sub>\n phase of cell cycle and restoration of p14<jats:sup>ARF<\/jats:sup> induced their apoptosis, followed by significant growth inhibition. Transduction of primary blast cells from chronic myeloid leukemia in blast crisis (CML-BC) and Ph-positive acute lymphoblastic leukemia (ALL) with p16<jats:sup>INK4a<\/jats:sup>\n or p14<jats:sup>ARF<\/jats:sup> virus also resulted in cell growth inhibition and\/or apoptosis with a patient-to-patient variation, whereas clonal growth and differentiation of cord blood progenitor cells were not affected by enforced expression of INK4a\/ARF. Furthermore, upon viral transduction at low\n multiplicity of infection, INK4a\/ARF potentiated the effect of imatinib mesylate on Ph-positive leukemia cell lines in an additive but not synergistic manner. These results suggest that INK4a\/ARF protein-mimetic agents may be promising options for Ph-positive leukemias in combination with imatinib mesylate.<\/jats:p>","DOI":"10.3727\/096504013x13786659070271","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T03:40:51Z","timestamp":1384314051000},"page":"23-31","source":"Crossref","is-referenced-by-count":6,"title":["Restoration of INK4a\/ARF Gene Inhibits Cell Growth and Cooperates With Imatinib Mesylate in Philadelphia Chromosome-Positive Leukemias"],"prefix":"10.32604","volume":"21","author":[{"given":"Yuansong","family":"Bai","sequence":"first","affiliation":[{"name":"Department of Hematology\/Oncology, China\u2013Japan Union Hospital of Jilin University, Changchun, Jilin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenxia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Butong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shibao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","reference":[{"key":"b1","first-page":"2995","article-title":"A novel p16INK4A transcript","volume":"55","year":"1995","journal-title":"Cancer Res."},{"key":"b2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0092-8674(95)90214-7","article-title":"Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest","volume":"83","year":"1995","journal-title":"Cell"},{"key":"b3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/375503a0","article-title":"Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16","volume":"375","year":"1995","journal-title":"Nature"},{"issue":"9","key":"b4","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1158\/0008-5472.CAN-12-3730","article-title":"Dynamics of senescent cell formation and retention revealed by p14ARF induction in the epidermis","volume":"73","year":"2013","journal-title":"Cancer Res."},{"key":"b5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0092-8674(00)81401-4","article-title":"ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways","volume":"92","year":"1998","journal-title":"Cell"},{"key":"b6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-0-387-69116-9_9","article-title":"The ARF tumor suppressor in acute leukemias: Insights from mouse models of Bcr-Abl-induced acute lymphoblastic leukemia","volume":"604","year":"2007","journal-title":"Adv. Exp. Med. Biol."},{"key":"b7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1182\/blood.V86.3.841.841","article-title":"Role of the cyclin-dependent kinase inhibitors in the development of cancer","volume":"86","year":"1995","journal-title":"Blood"},{"key":"b8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4149\/neo_2012_022","article-title":"Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia","volume":"59","year":"2012","journal-title":"Neoplasma"},{"key":"b9","first-page":"3730","article-title":"Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia","volume":"59","year":"1999","journal-title":"Cancer Res."},{"key":"b10","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1182\/blood.V97.9.2604","article-title":"The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells","volume":"97","year":"2001","journal-title":"Blood"},{"key":"b11","first-page":"136","article-title":"Co-transfection of p16(INK4a) and p53 genes into the K562 cell line inhibits cell proliferation","volume":"87","year":"2002","journal-title":"Haematologica"},{"key":"b12","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1182\/blood.V85.10.2643.bloodjournal85102643","article-title":"All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia","volume":"85","year":"1995","journal-title":"Blood"},{"key":"b13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V72.2.567.567","article-title":"Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia","volume":"72","year":"1988","journal-title":"Blood"},{"key":"b14","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nature03669","article-title":"Dynamics of chronic myeloid leukaemia","volume":"435","year":"2005","journal-title":"Nature"},{"key":"b15","doi-asserted-by":"crossref","first-page":"10700","DOI":"10.1073\/pnas.162140299","article-title":"Clinical resistance to the kinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop","volume":"99","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"b16","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/sj.leu.2402741","article-title":"Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy","volume":"16","year":"2002","journal-title":"Leukemia"},{"key":"b17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2002-05-1451","article-title":"Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemia","volume":"101","year":"2003","journal-title":"Blood"},{"key":"b18","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1182\/blood-2007-08-103499","article-title":"Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase: A phase 2 trial of the GIMEMA CML Working Party","volume":"113","year":"2009","journal-title":"Blood"},{"key":"b19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1182\/blood-2003-01-0025","article-title":"Result of high-dose imatinib mesylate in patients with Philadelphia chromosome-positive chronic myeloid leukemia after failure of interferon-alpha","volume":"102","year":"2003","journal-title":"Blood"},{"key":"b20","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1101\/gad.1673908","article-title":"Failure of CDKN2A\/B (INK4A\/B\u2013ARF)-mediated tumor suppression and resistance to targeted therapy in acute lymphoblastic leukemia induced by BCR-ABL","volume":"22","year":"2008","journal-title":"Genes Dev."},{"key":"b21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(02)07679-1","article-title":"BCR-ABL gene mutations in relation to clinical resistance of Philadelphia-chromosome-positive leukaemia to STI571: A prospective study","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"b22","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1182\/blood.V99.9.3472","article-title":"High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR\/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance","volume":"99","year":"2002","journal-title":"Blood"},{"key":"b23","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/sj.gt.3302026","article-title":"Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector","volume":"10","year":"2003","journal-title":"Gene Ther."},{"key":"b24","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1182\/blood-2003-06-1948","article-title":"A novel Maxizyme vector targeting a bcr-abl fusion gene induced specific cell death in Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"104","year":"2004","journal-title":"Blood"},{"key":"b25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0145-2126(01)00107-2","article-title":"Detection of p53 gene mutations by single strand conformational polymorphism (SSCP) in human acute myeloid leukemia-derived cell lines","volume":"26","year":"2002","journal-title":"Leuk. Res."},{"key":"b26","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0145-2126(93)90068-V","article-title":"Expression of differentially phosphorylated Rb and mutant p53 proteins in myeloid leukemia cell lines","volume":"17","year":"1993","journal-title":"Leuk. Res."},{"key":"b27","doi-asserted-by":"crossref","first-page":"e61064","DOI":"10.1371\/journal.pone.0061064","article-title":"Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"b28","doi-asserted-by":"crossref","first-page":"17343","DOI":"10.1074\/jbc.M111.314898","article-title":"p14(ARF)-induced apoptosis in p53 protein-deficient cells is mediated by BH3-only protein-independent derepression of Bak protein through down-regulation of Mcl-1 and Bcl-xL proteins","volume":"287","year":"2012","journal-title":"J. Biol. Chem."},{"key":"b29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1097-2765(03)00223-5","article-title":"p53- and Mdm2-independent repression of NF-kappa B transactivation by the ARF tumor suppressor","volume":"12","year":"2003","journal-title":"Mol. Cell"},{"key":"b30","first-page":"1046","article-title":"Arf induces p53-dependent and -independent antiproliferative genes","volume":"63","year":"2003","journal-title":"Cancer Res."},{"key":"b31","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/sj.leu.2401043","article-title":"Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells","volume":"12","year":"1998","journal-title":"Leukemia"},{"key":"b32","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1038\/sj.leu.2401557","article-title":"Expression of p16INK4A and p14ARF in hematological malignancies","volume":"13","year":"1999","journal-title":"Leukemia"},{"key":"b33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood.V86.1.311.bloodjournal861311","article-title":"p16INK4A and p15INK4B gene deletions in primary leukemias","volume":"86","year":"1995","journal-title":"Blood"},{"key":"b34","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1182\/blood.V85.8.2013.bloodjournal8582013","article-title":"Homozygous deletions of the p16 tumor-suppressor gene are associated with lymphoid transformation of chronic myeloid leukemia","volume":"85","year":"1995","journal-title":"Blood"},{"key":"b35","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2141.1995.tb05358.x","article-title":"Involvement of the cyclin-dependent kinase-4 inhibitor (CDKN2) gene in the pathogenesis of lymphoid blast crisis of chronic myelogenous leukaemia","volume":"91","year":"1995","journal-title":"Br. J. Haematol."},{"key":"b36","first-page":"837","article-title":"Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies","volume":"57","year":"1997","journal-title":"Cancer Res."},{"key":"b37","first-page":"771","article-title":"Expression of cell cycle regulatory genes in chronic myelogenous leukemia","volume":"83","year":"1998","journal-title":"Haematologica"},{"key":"b38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0301-472X(02)01075-5","article-title":"Genomic p16 abnormalities in the progression of chronic myeloid leukemia into blast crisis: A sequential study in 42 patients","volume":"31","year":"2003","journal-title":"Exp. Hematol."},{"key":"b39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0092-8674(00)81079-X","article-title":"Role of the INK4a locus in tumor suppression and cell mortality","volume":"85","year":"1996","journal-title":"Cell"},{"key":"b40","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1158\/0008-5472.CAN-05-2476","article-title":"Induction of nevi and skin tumors in Ink4a\/Arf Xpa knockout mice by neonatal, intermittent, or chronic UVB exposures","volume":"66","year":"2006","journal-title":"Cancer Res."},{"key":"b41","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1038\/sj.leu.2400840","article-title":"Inhibition of growth of human leukemia cell lines by retrovirally expressed wild-type p16INK4A","volume":"11","year":"1997","journal-title":"Leukemia"},{"key":"b42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2141.1996.d01-1913.x","article-title":"Transfer of p16inka\/CDKN2 gene in leukaemic cell lines inhibits cell proliferation","volume":"95","year":"1996","journal-title":"Br. J. Haematol."},{"key":"b43","first-page":"2482","article-title":"Flavopiridol induces apoptosis of normal lymphoid cells, causes immunosuppression, and has potent antitumor activity In vivo against human leukemia and lymphoma xenografts","volume":"91","year":"1998","journal-title":"Blood"},{"key":"b44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nature01587","article-title":"Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells","volume":"423","year":"2003","journal-title":"Nature"}],"container-title":["Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/cog\/or\/2013\/00000021\/00000001\/art00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,18]],"date-time":"2022-07-18T10:06:07Z","timestamp":1658138767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.3727\/096504013X13786659070271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,15]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,11,15]]}},"alternative-id":["0965-0407(20131115)21:1L.23;1-"],"URL":"https:\/\/doi.org\/10.3727\/096504013x13786659070271","relation":{},"ISSN":["0965-0407"],"issn-type":[{"value":"0965-0407","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11,15]]}}}